Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, September 2001, p. 997-1002, Vol. 8, No. 5
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.5.997-1002.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Seroprevalence of Antibodies to Microorganisms Known To Cause
Arterial and Myocardial Damage in Patients with or without
Coronary Stenosis
C.
Stöllberger,1,*
G.
Mölzer,1 and
J.
Finsterer2
Medizinische Abteilung der Krankenanstalt
Rudolfstiftung, A-1030 Vienna,1 and
Neurologisches Krankenhaus Rosenhügel und Ludwig
Boltzmann Institut für Epilepsie and neuromuskuläre
Erkrankungen, A-1130 Vienna,2 Austria
Received 29 May 2001/Returned for modification 28 June
2001/Accepted 16 July 2001
 |
ABSTRACT |
Infections are assumed to play a role in coronary artery disease
(CAD) and cardiomyopathies. It is unknown whether the seroprevalence of
antibodies to these microorganisms is higher in patients with than
without CAD. The seroprevalence of antibodies to Bartonella henselae, Borrelia burgdorferi, Chlamydia pneumoniae, Coxiella burnetii, Helicobacter pylori, human granulocytic
Ehrlichia, Leptospira, Rickettsia conorii, and
Treponema pallidum was assessed prospectively in patients
with exertional dyspnea or anginal chest pain who underwent coronary
angiography because of suspected CAD. Patients with normal angiograms
(NA) were those in whom no more than 50% stenosis of any coronary
artery was found. Patients with CAD were patients who underwent
percutaneous transluminal coronary angioplasty. There were 50 patients
with CAD (9 female) and 62 with NA (25 female), with a mean age
of 62 years. All patients had antibodies to at least one microorganism:
to B. henselae, 8% of CAD patients and
5% of NA patients; to B. burgdorferi IgG, 14% CAD and 6%
NA; to B. burgdorferi IgM, 6% CAD and 3%
NA; to C. pneumoniae lipopolysaccharide (LPS) IgA, 76% CAD
and 77% NA; to C. pneumoniae LPS
IgG, 80% CAD and 90% NA; to C. burnetii, 0% CAD and 5%
NA; to H. pylori, 92% CAD and 68% NA; to human
granulocytic Ehrlichia, 8% CAD and 3% NA; to
Leptospira IgG, 4% CAD and 2% NA; to R. conorii, 10% in both groups; and to T. pallidum, 2%
CAD and 0% NA. The seroprevalence of antibodies to micro-organisms
known to induce arterial and myocardial damage does not differ between
patients with CAD and NA.
 |
INTRODUCTION |
Infections are assumed to play a role in the
pathogenesis of coronary artery disease (CAD) and cardiomyopathies.
Among microorganisms known to cause arterial and myocardial
damage are Bartonella henselae, Borrelia burgdorferi,
Chlamydia pneumoniae, Coxiella burnetii, Helicobacter
pylori, human granulocytic Ehrlichia, Leptospira, Rickettsia
conorii, and Treponema pallidum (4, 8, 13, 14,
16, 26, 27, 28). It is unknown, however, whether the
seroprevalence of antibodies to these microorganisms is higher in
patients with coronary heart disease than in those without coronary
heart disease who suffer from exertional dyspnea or anginal chest pain.
Therefore, a prospective study was carried out with patients with
exertional dyspnea or anginal chest pain who underwent a coronary
angiography because of suspected coronary heart disease based on
pathologic findings on stress test, scintigraphy, and echocardiography.
Aims of the study were (i) to compare the seroprevalence of specific
antibodies to microorganisms known to cause arterial and
myocardial damage between patients with normal angiograms and
patients with coronary heart disease and (ii) to assess the seroprevalence of antibodies to microorganisms known to cause arterial
and myocardial damage in patients with normal angiograms with regard to
(a) possible causes of exertional dyspnoea and anginal chest pain, like
arterial hypertension, hemochromatosis, hypothyroidism,
hypoparathyroidism, tachycardiomyopathy, amyloidosis, and neuromuscular
disorders, and (b) echocardiographic findings (17).
 |
MATERIALS AND METHODS |
Patients.
The group of patients with normal angiograms
consisted of consecutive patients in whom a coronary angiography had
been performed because coronary heart disease was suspected by clinical
findings (exertional dyspnea or anginal chest pain) and noninvasive
tests (stress test, scintigraphy, and echocardiography) and no relevant (>50%) stenosis of any coronary artery had been found. Excluded were
patients in whom a coronary angiography was performed prior to valve
surgery or organ transplantation. The group of patients with coronary
heart disease consisted of consecutive patients who underwent
percutaneous transluminal coronary angioplasty (PTCA) of one or more
coronary artery stenosis. The coronary angiographies and PTCA were
performed at the 2nd Medical Department of the Krankenanstalt Rudolfstiftung. All patients of both groups were invited for a follow-up visit between April and July 1999. During this visit, patients with normal coronary angiograms underwent extensive
investigations, including a medical history, physical
examination, 12-lead electrocardiogram (ECG), transthoracic 2-D, M-mode
and Doppler echocardiography, and blood tests (blood sedimentation
rate, red and white blood cell counts, thrombocyte count, transferrin
saturation, creatine kinase,
-glutamyl-transpeptidase, calcium,
potassium, thyroid stimulating hormone, and analysis of the
hemochromatosis gene mutations C282Y and H63D). Based on these
investigations, possible causes of dyspnea and anginal chest pain were
assessed according to predefined criteria (Table
1) (17). Patients with
coronary heart disease underwent clinical examination and exercise
testing 3 months after PTCA. At this visit, blood was taken from both groups for serologic investigations comprising specific antibodies to
the following microorganisms, which are known to cause arterial and myocardial damage: B. henselae, B. burgdorferi, C. pneumoniae, C. burnetii, H. pylori, human granulocytic
Ehrlichia, Leptospira, R. conorii, and T. pallidum. The test systems used are listed on Table
2. All tests were performed according to
the manufacturer's instructions at one institute (Klinisches Institut
für Hygiene der Universität Wien). Informed consent was
obtained from all patients, and the study was approved by the
institutional ethics committee.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Diagnostic criteria for possible causes of symptoms and
their prevalence in group of patients with normal angiograms
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Test systems used in order to identify specific
antibodies to selected pathogens in sera of patients with cardiac
symptomsa
|
|
 |
RESULTS |
Included in the study were 112 patients, 50 with coronary heart
disease who underwent PTCA between January and April 1999 and 62 with
normal coronary angiograms performed between January and December 1998. The group with coronary heart disease consisted of 9 female and 41 male patients with a mean age of 62 years. In the group with
normal coronary angiograms (25 female, 37 male, mean age of 62 years),
the patients suffered from anginal chest pain (n = 38 [61%]), exertional dyspnea (n = 12 [19%]),
or a combination of exertional dyspnea and anginal chest pain
(n = 12 [19%]). In this group, all patients except
one underwent one or more noninvasive tests prior to coronary
angiography: echocardiography (n = 25), bicycle stress
test (n = 3), echocardiography and bicycle stress test
(n = 14), echocardiography and scintigraphy
(n = 6), bicycle test and scintigraphy (n = 1), or echocardiography, bicycle test, and scintigraphy
(n = 12). In patients with normal coronary angiograms, 47 patients had smooth normal vessels and 15 patients had coronary sclerosis but no significant (>50%) stenosis. In 48 of the 62 patients with normal coronary angiograms, one or more causes of cardiac
symptoms could be assessed: arterial hypertension (n = 44), hemochromatosis (n = 2), hypothyroidism
(n = 3), tachycardiomyopathy (n = 5),
and neuromuscular disorder (n = 7). In the remaining 14 patients with normal coronary angiograms, the cause of exertional dyspnea and anginal chest pain remained unknown (Table 1)
(17). The seroprevalence of antibodies known to cause
arterial and myocardial damage is listed on Table
3. All included patients had antibodies to at least one microorganism. The seroprevalence was similarly distributed between patients with coronary artery stenosis and with
normal coronary angiograms. Antibodies to C. pneumoniae
and H. pylori were most prevalent in both groups.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Seroprevalence of antibodies to microorganisms known to
cause arterial and myocardial damage in patients with exertional
dyspnea with coronary heart disease and with normal coronary
angiogramsa
|
|
In the group with coronary heart disease, five patients had antibodies
only to H. pylori, and four patients had only
C. pneumoniae IgG and IgA. Antibodies to two different
microorganisms were found in 25 patients, most commonly a combination
of antibodies to H. pylori and C. pneumoniae IgG and IgA (n = 19). Antibodies to
three microorganisms were found in nine patients, to four
microorganisms in five patients, and to five microorganisms in two patients.
In the group with normal coronary angiograms, 3 patients had antibodies
only to H. pylori and 14 patients had antibodies only to C. pneumoniae IgG and IgA. Antibodies to two
different microorganisms were found in 35 patients, most commonly a
combination of antibodies to H. pylori and to
C. pneumoniae IgG and IgA (n = 21).
Antibodies to three microorganisms were found in seven patients and to
four microorganisms in three patients. The seroprevalence of antibodies in the group with normal coronary angiograms with regard to the possible causes of their symptoms and echocardiographic findings are
listed on Tables 4 and
5. Within the group with normal coronary angiograms, the seroprevalence did not differ between patients with
smooth normal vessels and patients with coronary sclerosis (data not
shown).
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Antibodies to microorganisms known to cause arterial and
myocardial damage, possible causes for cardiac symptoms, and
echocardiographic findings in 48 patients with normal coronary
angiogramsa
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Antibodies to microorganisms known to cause arterial and
myocardial damage and echocardiographic findings for 14 patients
with normal coronary angiograms with no possible causes for cardiac
symptoms
|
|
 |
DISCUSSION |
This study shows that the seroprevalence of microorganisms known
to induce arterial and myocardial damage is similar in patients with
exertional dyspnea and anginal chest pain, irrespective if they have
normal coronary angiograms or coronary heart disease. In patients with
normal angiograms, the seroprevalence of antibodies to microorganisms
known to cause arterial and myocardial damage does not differ
with regard to (i) possible causes of exertional dyspnea and
anginal chest pain, like arterial hypertension, hemochromatosis, hypothyroidism, tachycardiomyopathy, and neuromuscular disorders, and
(ii) echocardiographic findings.
An association of coronary heart disease and infections with
C. pneumoniae, an important respiratory pathogen, has
been initially found by seroepidemiologic studies (23).
More recently, the presence of C. pneumoniae in
atheromatous plaques has been shown (3). At present,
controversial results are available about the role of C. pneumoniae in the development of coronary heart disease. Several
authors found an association (18, 24) whereas others did
not (5, 6). Another microorganism suspected to play a role
in coronary artherosclerosis is H. pylori, the main etiological factor in gastritis and peptic ulcer disease. H. pylori infection is postulated to have an effect on clotting
mechanisms and lead to a prothrombotic state (10). Again,
controversial results are available about the role of H. pylori in the development of coronary heart disease. Several
authors found an association (20), whereas others did not
(5, 10, 18), or found an association which can be
adequately explained by the much stronger association of H. pylori infection with age and social class, both of which are
linked with coronary heart disease (15). Nearly all our
patients with coronary stenosis (92%) had antibodies to H. pylori, whereas in the group with normal coronary
angiograms, they were found in only 68% of the patients. This finding
may be due to the differing proportions of male patients in the
group with coronary heart disease (82%) and with normal coronary
angiograms (60%). Furthermore, epidemiological studies show that the
seroprevalence of antibodies to H. pylori is generally
higher in men than women (15, 22). One reason for the
controversial results about the association of infections with
C. pneumoniae or H. pylori with coronary heart disease might be that some of the studies compared patients with coronary heart disease and asymptomatic controls (6, 18, 20, 23, 24), whereas other studies, like the present one, compared symptomatic patients with and without coronary artery stenosis (10).
In the absence of coronary heart disease, exertional dyspnea and
anginal chest pain may be caused by extracardiac causes, like
pulmonary, skeletal, gastrointestinal, haematological, or neurologic
disorders, by vascular causes like arterial hypertension or
aortic dissection, or by myocardial damage due to inflammation, fibrosis, intoxication, storage, and neuromuscular disorders leading to
left ventricular dilatation, wall thickening, and impaired diastolic
and systolic function. The role of microorganisms to induce myocardial
damage without affecting the coronary arteries is best established for
B. burgdorferi (11, 25, 26). Infection with
B. burgdorferi may lead to left ventricular dilatation
and systolic dysfunction and should be a differential diagnosis in patients presenting with these findings. As listed in Tables 4 and 5,
all four patients with antibodies to B. burgdorferi IgG presented with left ventricular dilatation. Since no myocardial biopsy
has been performed for these patients, cardiac borreliosis could not be
definitively diagnosed in these patients, but it might be an
explanation for their exertional dyspnea and anginal chest pain,
especially in the three cases in which no other cause could be assessed
(Table 5). Myocardial damage due to myocarditis, leading to heart
failure and sudden cardiac death, has been described for infections
with C. pneumoniae (28),
Ehrlichia (8), R. conorii
(16), and Coxiella (14). Cardiac
involvement in leptospirosis has been described as ECG abnormalities
and pericarditis (27). Myocardial damage by
Bartonella and Treponema organisms has been shown
in animals (1, 4, 13). Whether these microorganisms cause
myocardial damage also in humans is at present unknown.
A limitation of our study is the small number of patients. Therefore,
statistical valid tests about associations could not be
calculated. Further limitations are the lack of a serologic follow-up
and of myocardial biopsies in patients with normal coronary angiograms
and serologic findings suggestive of an infection. Additionally,
testing for other antibodies to microorganisms known to induce arterial
damage, like cytomegalovirus, or myocardial damage, like viruses, other
bacteria, fungi, and protozoa, has not been performed.
It is concluded that assessment of the seroprevalence of antibodies to
microorganisms known to induce arterial and myocardial damage is not
useful to clarify the etiology of exertional dyspnea or anginal chest
pain in patients with normal coronary angiograms, since they are
similarly distributed as in the general population and do not differ
between patients with coronary artery stenosis and with normal coronary
angiograms. These findings from a relatively small number of patients
have to be confirmed in a larger study.
 |
ACKNOWLEDGMENT |
We appreciate the work of Gerold Stanek, Klinisches Institut
für Hygiene der Universität Wien, Vienna, Austria, who
performed the serologic tests.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Steingasse
31/18, A-1030 Vienna, Austria. Phone and Fax: 43 1 713 98 70. E-mail:
claudia.stoellberger{at}chello.at.
 |
REFERENCES |
| 1.
|
Breitschwerdt, E. B.,
C. E. Atkins,
T. T. Brown,
D. L. Kordick, and P. S. Snyder.
1999.
Bartonella vinssonii subsp. berkhoffii and related members of the alpha subdivision of the Proteobacteria in dogs with cardiac arrhythmias, endocarditis, or myocarditis.
J. Clin. Microbiol.
37:3618-3626[Abstract/Free Full Text].
|
| 2.
|
Brugada, P., and E. Andries.
1993.
"Tachycardiomyopathy." The most frequently unrecognized cause of heart failure?
Acta Cardiol.
48:163-169.
|
| 3.
|
Campbell, L. A.,
E. R. O'Brien,
A. L. Cappuccio,
C.-C. Kuo,
S.-P. Wang,
D. Stewart,
D. L. Patton,
P. K. Cummings, and J. T. Grayston.
1995.
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.
J. Infect. Dis.
172:585-588[Medline].
|
| 4.
|
Casavant, C. H.,
V. Wicher, and K. Wicher.
1978.
Host response to Treponema pallidum infection. III. Demonstration of autoantibodies to heart in sera from infected rabbits.
Int. Arch. Allergy Appl. Immunol.
56:171-178[Medline].
|
| 5.
|
Choussat, R.,
G. Montalescot,
J. Collet,
C. Jardel,
A. Ankri,
A.-M. Fillet,
D. Thomas,
J. Raymond,
J.-P. Bastard,
G. Drobinski,
J. Orfila,
H. Agut, and D. Thomas.
2000.
Effect of prior exposure to Chlamydia pneumoniae. Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction.
Am. J. Cardiol.
86:379-384[CrossRef][Medline].
|
| 6.
|
Danesh, J.,
P. Whincup,
M. Walker,
L. Lennon,
A. Thomson,
P. Appleby,
Y.-K. Wong,
M. Bernardes-Silva, and M. Ward.
2000.
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.
Br. Med. J.
321:208-213[Abstract/Free Full Text].
|
| 7.
|
Feder, J. N.,
A. Gnirke,
W. Thomas,
Z. Tsuchihashi,
D. A. Ruddy,
A. Basava,
F. Dormishian,
R. Domingo, Jr.,
M. C. Ellis,
A. Fullan,
L. M. Hinton,
N. L. Jones,
B. E. Kimmel,
G. S. Kronmal,
P. Lauer,
V. K. Lee,
D. B. Loeb,
F. A. Mapa,
E. McClelland,
N. C. Meyer,
G. A. Mintier,
N. Moeller,
T. Moore,
E. Morikang,
C. E. Prass,
L. Quintana,
S. M. Starnes,
R. C. Schatzman,
K. J. Brunke,
D. T. Drayna,
N. J. Risch,
B. R. Bacon, and R. K. Wolff.
1996.
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.
Nat. Genet.
13:399-408[CrossRef][Medline].
|
| 8.
|
Jahangir, A.,
C. Kolbert,
W. Edwards,
P. Mitchell,
J. S. Dumler, and D. H. Persing.
1998.
Fatal pancarditis associated with human granulocytic Ehrlichiosis in a 44-year-old man.
Clin. Infect. Dis.
27:1424-1427[Medline].
|
| 9.
|
Jerusalem, F., and S. Zierz.
1991.
Muskelerkrankungen.
Klinik, Therapie, Pathologie. Thieme, Stuttgart, Germany.
|
| 10.
|
Khurshid, A.,
T. Fenske,
T. Bajwa,
K. Bourgeois, and N. Vakil.
1998.
A prospective, controlled study of Helicobacter pylori seroprevalence in coronary artery disease.
Am. J. Gastroenterol.
93:717-720[CrossRef][Medline].
|
| 11.
|
Klein, J.,
G. Stanek,
R. Bittner,
R. Horvat,
C. Holzinger, and D. Glogar.
1991.
Lyme borreliosis as a cause of myocarditis and heart muscle disease.
Eur. Heart J.
12(Suppl. D):73-75.
|
| 12.
|
Kudoh, C.,
S. Tanaka,
S. Marusaki,
N. Takahashi,
Y. Miyazaki,
N. Yoshioka,
M. Hayashi,
K. Shimamoto,
K. Kikuchi, and O. Iimura.
1992.
Hypocalcemic cardiomyopathy in a patient with idiopathic hypoparathyroidism.
Intern. Med.
31:561-568[Medline].
|
| 13.
|
La Scola, B., and D. Raoult.
1999.
Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998).
J. Clin. Microbiol.
37:1899-1905[Abstract/Free Full Text].
|
| 14.
|
Maisch, B.
1986.
Rickettsial perimyocarditis a follow-up study.
Heart Vessels
2:55-59[CrossRef][Medline].
|
| 15.
|
McDonagh, T. A.,
M. Woodward,
C. E. Morrison,
J. J. V. McMurray,
H. Tunstall-Pedoe,
G. D. O. Lowe,
K. E. L. McColl, and H. J. Dargie.
1997.
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population.
Eur. Heart J.
18:1257-1260[Abstract/Free Full Text].
|
| 16.
|
Milon, H.,
J. Pasquier,
R. Loire,
F. Guillermet,
F. Brun,
L. Descos, and V.-T. Minh.
1970.
Insuffisance cardiaque aigue avec séro-agglutination positive pour Rickettsia conori.
Arch. Mal. Coeur Vaiss.
63:1635-1646[Medline].
|
| 17.
|
Mölzer, G.,
J. Finsterer,
W. Krugluger,
G. Stanek, and C. Stöllberger.
2001.
Possible causes of symptoms in suspected coronary heart disease but normal angiograms.
Clin. Cardiol.
24:307-312[Medline].
|
| 18.
|
Ossewaarde, J. M.,
E. J. Feskens,
A. De Vries,
C. E. Vallinga, and D. Kromhoumessiat.
1998.
Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not.
Epidemiol. Infect.
120:93-99[CrossRef][Medline].
|
| 19.
|
Phatak, P. D.,
R. L. Sham,
R. F. Raubertas,
K. Dunnigan,
M. T. O'Leary,
C. Braggins, and J. D. Cappuccio.
1998.
Prevalence of hereditary hemochromatosis in 16 031 primary care patients.
Ann. Intern. Med.
129:954-961[Abstract/Free Full Text].
|
| 20.
|
Pieniazek, P.,
E. Karczewska,
A. Duda,
W. Tracz,
M. Pasowicz, and S. J. Konturek.
1999.
Association of Helicobacter pylori infection with coronary heart disease.
J. Physiol. Pharmacol.
50:742-751.
|
| 21.
|
Reisinger, J.,
S. W. Dubrey, and R. H. Falk.
1997.
Cardiac amyloidosis.
Cardiol. Rev.
5:317-325.
|
| 22.
|
Russo, A.,
M. Eboli,
P. Pizetti,
G. Di Felice,
F. Ravagnani,
P. Spinelli,
A.-M. Hotz,
P. Notti,
G. Maconi,
S. Franceschi,
D. Ferrari, and L. Bertario.
1999.
Determinants of Helicobacter pylori seroprevalence among Italian blood donors.
Eur. J. Gastroenterol. Hepatol.
11:867-873[Medline].
|
| 23.
|
Saikku, P.,
K. Mattila,
M. S. Nieminen,
J. K. Huttunen,
M. Leinonen,
M.-R. Ekman,
P. H. Makela, and V. Valtonen.
1988.
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.
Lancet
ii:983-986.
|
| 24.
|
Sessa, R.,
M. Di Pietro,
I. Santino,
M. del Piano,
A. Varveri,
A. Dagianti, and M. Penco.
1999.
Chlamydia pneumoniae infection and atherosclerotic coronary disease.
Am. Heart J.
137:1116-1119[CrossRef][Medline].
|
| 25.
|
Sonnesyn, S. W.,
S. C. Diehl,
R. C. Johnson,
H. Kubo Spencer, and J. L. Goodman.
1995.
A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure.
Am. J. Cardiol.
76:97-100[CrossRef][Medline].
|
| 26.
|
Stanek, G.,
J. Klein,
R. Bittner, and D. Glogar.
1990.
Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy.
N. Engl. J. Med.
322:249-252[Medline].
|
| 27.
|
Watt, G.,
L. P. Padre,
M. Tuazon, and C. Calubaquib.
1990.
Skeletal and cardiac muscle involvement in severe, late leptospirosis.
J. Infect. Dis.
162:266-269[Medline].
|
| 28.
|
Wesslen, L.,
C. Pahlson,
G. Friman,
J. Fohlman,
O. Lindquist, and C. Johansson.
1992.
Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a swedish elite orienteer.
Lancet
340:427-428[Medline].
|
Clinical and Diagnostic Laboratory Immunology, September 2001, p. 997-1002, Vol. 8, No. 5
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.5.997-1002.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Stollberger, C., Finsterer, J.
(2002). Role of Infectious and Immune Factors in Coronary and Cerebrovascular Arteriosclerosis. CVI
9: 207-215
[Full Text]